Implantable-glucose responsive insulin delivery device

• US 8,702,645 B2
• Filed: 05/05/2011
• Issued: 04/22/2014
• Est. Priority Date: 05/05/2010
• Status: Active Grant

• Current Assignee: The Governing Council of the University of Toronto (University of Toronto)
• Original Assignee: The Governing Council of the University of Toronto (University of Toronto)
• Inventors: Wu, Xiao Yu, Zhang, Kai, Huang, Huiyu, Gordijo, Claudia
• Primary Examiner(s): Sirmons, Kevin C
• Assistant Examiner(s): Hall, Deanna K
• Application Number:
  US13/101,634
• Publication Number:
  US 20110276025A1
• Time in Patent Office: 1,083 Days
• Field of Search: 604/890.1, 604/66, 604/503, 424424-426
• US Class Current: 604/66
• CPC Class Codes: A61M 2205/0227 Materials having sensing or indicating function, e.g. indicating a pressure increase
• CPC Class Codes: A61M 2230/201 Glucose concentration
• CPC Class Codes: A61M 5/14276 specially adapted for implantation

Abstract

A biocompatible insulin delivery device is provided comprising an insulin reservoir sealed with a glucose-responsive plug or membrane. The plug functions to release insulin from the reservoir in response to a hyperglycemic glucose concentration and to prevent insulin release from the reservoir in response to hypoglycemic glucose concentration. In one embodiment, the plug is made of a biocompatible polymeric matrix comprising an inorganic component, a stimulus-responsive component and a catalytic component.

Claims

1. A biocompatible insulin delivery device comprising a reservoir for insulin and a glucose-responsive plug that seals the reservoir,

wherein the plug comprises a polymeric matrix having an inorganic component and a stimulus-responsive component adapted to alter the porosity of the plug in response to a stimulus and wherein the plug functions to release insulin from the reservoir in response to a hyperglycemic glucose concentration and to prevent insulin release from the reservoir in response to a hypoglycemic glucose concentration.

2. The device of claim 1, wherein the reservoir is made of a biocompatible material selected from the group consisting of synthetic polymer, natural polymer, metal, glass, ceramic and hybrid materials formed with biocompatible metal, glass or ceramics with one or more polymers.

3. The device of claim 1, wherein the reservoir is made of a polymer selected from the group consisting of collagen, starch blends, hyaluronic acid, alginates, carrageenan, silicone rubbers, polydimethylsiloxane, polyurethanes, acrylic polymers, poly(methyl methacrylate), polyesters, cellulose derivatives, cellulose acetate, polyethylene terephthalate, polycarbonate, polysulfone, polyvinyl chloride, polyethylene, polypropylene, polymethylacrylate and nylon.

4. The device of claim 2, wherein the material is surface modified to include PEG or silane groups.

5. The device of claim 1, wherein the stimulius-responsive component comprises a composite of at least one hydrogel that changes porosity when exposed to a stimulus and at least one second polymer or polymer mixture that does not change when exposed to the stimulus.

6. The device of claim 5, wherein the hydrogel is selected from the group consisting of poly(ethylene oxide), polymers of R-acrylamide, R-acrylate or R₁-acrylic acid, and R, R₁, R₂-cellulose in which R, R₁, and R₂ may be H or alkyl.

7. The device of claim 5, wherein the second polymer is selected from the group consisting of crosslinked proteins and derivatives thereof, ethylcellulose, methylcellulose, propylcellulose, methoxypropylcellulose, hydroxypropylmethylcellulose, cellulose nitrate, poly(vinyl alcohol), poly(vinyl chloride), polystyrene, polyethylene, polypropylene, poly(ethylene-co-vinyl acetate), polyesters, poly(hydroxybutyric acid), poly(hydroxyvalerianic acid-co-hydroxybutyric acid), poly(lactic acid), poly(glycolic acid), poly(lactic acid-co-glycolic acid), poly(ε

-caprolactones), poly(s-caprolactone-co-DL-lactic acid), polyanhydrides, poly(maleic anhydride), polyamides, albumin, gelatin, chitosan, collagen, pol(hydroxyalkyl)-L-glutamines, poly(γ

-ethyl-L-glutaminate-co-glutamic acid), poly(L-leucine-co-L-aspartic acid), poly(proline-co-glutamic acid), poly(orthoesters), poly(alkyI2-cyanoacrylates), polylysin, alginate, alginic acid, polyurethanes, poly(methyl methacrylate), poly(methyl methacrylate-co-methacrylic acid) and poly(methacrylate-co-hydroxypropyl methacrylate).

8. The device of claim 5, wherein the stimulus-responsive component comprises a catalytic component that catalyzes the change in porosity in the hydrogel component in response to a change in the glucose level.

9. The device of claim 8, wherein the catalytic component comprises glucose oxidase.

10. The device of claim 9, wherein the catalytic component additionally comprises catalase.

11. The device of claim 1, wherein the inorganic component comprises inorganic particles selected from the group of particles suitable stabilize the polymeric matrix, particles suitable to quench hydrogen peroxide, particles suitable to regenerate oxygen and particles suitable to stabilize glucose oxidase.

12. The device of claim 11, wherein the inorganic component comprises one or more of Mn02, Ag, Au, Si02, titanium, iron, magnesium, silica-based materials and carbon-based nanomaterials.

13. The device of claim 12, wherein the plug comprises inorganic particles in an amount in the range of about 0.01%-25% (w/w).

14. The device of claim 1, wherein the reservoir comprises an insulin formulation.

15. A method of treating diabetes in a mammal comprising implanting in the mammal a device as defined in claim 14.

16. The method of claim 15, wherein the device is implanted subcutaneously or intraperitoneally.

17. The device of claim 14, wherein the insulin formulation comprises hydroxypropyl methylcellulose.